In 2008 over 1,000,000 people were diagnosed with colon cancer (colorectal or bowel cancer) and over 600,000 of those diagnosed globally died from the disease. It is the third leading cause of cancer deaths in the United States. Current colon cancer treatments are extremely toxic and do not work for all patients.
Cannabidiol (CBD) seems to carry less of a stigma than tetrahydrocannabinol (THC), the psychoactive agent of marijuana which causes the “high” marijuana is known for, and shows promise as a way to treat a variety of cancers, therefore, CBD has received a great deal of attention in recent years.
A fairly recent study (October 2013) partially funded with grants from GW Pharmaceuticals and done by researchers in Italy and the UK and published in the journal Phytomedicine and online by the National Institute of Health has shown that a
Cannabis sativa extract containing a high content of cannabidiol (CBD) reduced the cell growth in colon cancer tumors but did not harm healthy cells. Pre-cancerous lesions were also reduced. The study was conducted on mice. These results could have clinical relevance for the use of cannabis-based medicines in cancer patients. In December 2014 there was a report published in the International Journal of Phototherapy and Psychopharmacology which showed that the use of high-CBD oil on actual patients not only stopped the cancerous cells from spreading it left the healthy cells alone.
There are many anecdotes from the general population claiming CBD oil cured their varied cancers. To the medical community, however, these are just stories. They need hard data. More studies are needed to further investigate the exciting prospects offered by CBD oil. Meanwhile, more and more people are turning to this “miracle oil” in hopes it will cure their disease. – www.cbdhempoilproductbenefits.com
